Epaminondas Doxakis

Epaminondas Doxakis is a Principal Investigator at the Biomedical Research Foundation of the Academy of Athens (BRFAA), where he leads a laboratory studying post-transcriptional regulation in Parkinson’s disease and related neurodegenerative disorders. He earned an MSc from Eötvös Loránd University, a PhD from the University of St Andrews, completed postdoctoral training at the University of Edinburgh and the Cardiff School of Biosciences, and holds an MBA from Edinburgh Business School. His work spans SNCA mRNA regulation, RNA-binding proteins and stress granule biology, non-coding RNAs (miRNAs, circRNAs, tRFs), ASO development, and RNA biomarker discovery. He coordinates multi-site collaborations.